Literature DB >> 12213403

Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis.

Arnab Acharya1, Jose Luis Diaz-Ortega, Gina Tambini, Ciro de Quadros, Isao Arita.   

Abstract

BACKGROUND: In 1994, the Americas set a goal of interrupting indigenous measles transmission from the Western Hemisphere by 2000. To accomplish this goal, the Pan American Health Organization (PAHO) developed an enhanced measles vaccination strategy.
METHODS: Cost data was collected at PAHO for Latin American and Caribbean (LAC) countries covering 96% of the region's population on components of the routine programs, and the 'follow-up' activities from member countries. In order to interpret our findings we have compared the present scenario regarding measles with one that would have ensued if past trends continued.
RESULTS: For the entire LAC population, estimated cost of elimination program will be US$ 571 million in present value terms.
INTERPRETATION: The vaccination strategy toward achieving elimination of measles costs USD 244 million, incremental from the cost of vaccination before the elimination program. Within 2000-2020, the current program will have prevented the occurrence of 3.2 million cases of measles and 16,000 deaths. Thus, vaccination strategy prevents a single case of measles at the cost of USD 71.75 and prevents a death due to measles at the cost of USD 15,000. The case fatality rate depends on a well functioning treatment program for measles cases. The vaccination strategy saves a total of USD 208 million in treatments costs due to reduced incidence of measles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213403     DOI: 10.1016/s0264-410x(02)00296-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.

Authors:  Kuti Bankole Peter; Adegoke Samuel Ademola; Oyelami Akibu Oyeku
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  Physical accessibility and utilization of health services in Yemen.

Authors:  Abdullah Al-Taiar; Allan Clark; Joseph C Longenecker; Christopher J M Whitty
Journal:  Int J Health Geogr       Date:  2010-07-21       Impact factor: 3.918

3.  Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.

Authors:  Carol E Levin; Hoang Van Minh; John Odaga; Swampa Sarit Rout; Diep Nguyen Thi Ngoc; Lysander Menezes; Maria Ana Mendoza Araujo; D Scott LaMontagne
Journal:  Bull World Health Organ       Date:  2013-06-19       Impact factor: 9.408

4.  It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger.

Authors:  Justine I Blanford; Supriya Kumar; Wei Luo; Alan M MacEachren
Journal:  Int J Health Geogr       Date:  2012-06-27       Impact factor: 3.918

Review 5.  Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic Review.

Authors:  Elisa Sicuri; David B Evans; Fabrizio Tediosi
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

6.  Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015.

Authors:  Eduardo A Undurraga; Martin I Meltzer; Cuc H Tran; Charisma Y Atkins; Melissa D Etheart; Max F Millien; Paul Adrien; Ryan M Wallace
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

7.  Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011-2012.

Authors:  Joseph Njau; Denisa Janta; Aurora Stanescu; Sarah S Pallas; Adriana Pistol; Nino Khetsuriani; Susan Reef; Daniel Ciurea; Cassandra Butu; Aaron S Wallace; Laura Zimmerman
Journal:  Emerg Infect Dis       Date:  2019-06       Impact factor: 6.883

8.  Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.

Authors:  Stéphane Verguet; Waasila Jassat; Melanie Y Bertram; Stephen M Tollman; Christopher J L Murray; Dean T Jamison; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-03-01       Impact factor: 2.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.